![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Tuesday, August 24, 2021 8:55:02 AM
now that it is common knowledge ibuprofen and acetaminophen are awesome for acute pain there is no excuse for a doctor declaring "Generic opioids are the mainstay of acute pain control in modern medicine." in 2021. It reflects a lack of understanding of the risk of opioids and a failure to keep up to date with current recommended practices.
Thanks for the medical advice from Dr. Google. LOL. Notice the date on the studies cited? Most were pre-2010. Hard to believe that with all this 10+ year-old "current" data that Percocet and Norco are still in the billion dollar range for annual sales. What does that tell you? It tells you that in the real world in 2021, opioids remain a mainstay of acute pain management. It tells you that NSAIDS are helpful to reduce opioid usage, but they are not a replacement. It tells you that NSAIDS are helpful for certain types of pain, like the dental pain and extremity sprains cited in your studies, but they not sufficient for all kinds of acute pain. It tells you that NSAIDS are even more toxic than opioids in a lot of ways, and they are not appropriate for many patients. NSAIDS can cause heart attacks and strokes, especially in older patients and anyone with pre-existing cardiac disease. NSAIDS cause CHF exacerbations. NSAIDS inhibit platelet function and are especially risky in post-op patients and anyone taking blood thinners. NSAIDS cause esophagitis and (hemorrhagic) peptic and duodenal ulcers. NSAIDS cause kidney failure. NSAIDS delay bone healing. I sincerely hope that anyone who is dealing with acute, severe pain for any reason has a medical practitioner with better management skills than those found in 10+ year-old links from the Minnesota Dental Association. Good luck with that, and I really mean it.
With all of this data from the 2000's showing the uselessness of opioids, it really makes one wonder why Hakim would commit all of our time and money to developing them.
#FreeSequestOx
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM